UK gets £100m stem cell boost
By The Register,
The Register
| 12. 02. 2005
The UK's stem cell research programmes will benefit from £100m over the next two years after Gordon Brown doubled the government's financial committement to the technology, Reuters reports. Brown said the cash would go to "pre-commercial aspects of stem cell research" - considered high-risk by pharmaceutical companies - and the recently-established UK Stem Cell Foundation.
More specifically, the money was destined for "clinical trials within the state health service, research into cell production facilities" and support for the UK's stem cell bank.
Brown said at an enterprise conference in London: "Britain should be the world's number one centre for genetic and stem cell research, building on our world leading regulatory regime in the area."
The UK has already adopted a rigourous pro-research stance in the face of widespread opposition to the technology. Back in March, it declared it would ignore a non-binding UN ban on human cloning, at least as far as therapeutic cloning is concerned. Health secretary John Reid noted: "Reproductive cloning is already illegal in the UK. Anyone attempting it in this country faces a 10-year prison sentence...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Ian Sample, The Guardian | 03.08.2024
Scientists are a step closer to making IVF eggs from patients’ skin cells after adapting the procedure that created Dolly the sheep, the first cloned mammal, more than two decades ago.
The work raises the prospect of older women being...
By Ramon Antonio Vargas, The Guardian | 02.28.2024
Doctors say a man in California who contracted blood cancer while living with HIV is in remission from both potentially fatal illnesses thanks to a treatment they are hailing as remarkable and encouraging.
Paul Edmonds is only the fifth-known person...
By Victoria Gray, Uduak Thomas, and Kevin Davies, The CRISPR Journal | 02.14.2024
In July 2019, medical staff in Nashville dosed the first U.S. patient in the exa-cel therapy trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. That first patient was Victoria Gray, a mother of four from Forest, Mississippi, a sickle cell...